CTTH - CTT Pharma Updates On Worldwide Patent Portfolio
(TheNewswire)
Tampa, Florida, United States - The Newswire – December 19, 2022 -CTT Pharmaceutical Holdings, Inc.(OTC:CTTH) has received patentapproval in Israel for our dissolvable strip technology. This latestpatent approval gives CTT up to 48 granted patents, including threepatents in the United States, three in Canada, Europe, Australia,South Africa, Mexico, and Israel. Europe covers up to 38 countries,which includes The United Kingdom, Germany, France, Switzerland, andItaly to name a few.
CTT also has 9 patents pending, which includes four patents pending inthe United States, three in Canada, Brazil, and Chile. In 2021 CTTsecured pending patents in the US and Canada to cover Psychedelicsusing our technology and in 2022 CTT strengthened our patents byfiling a continuation from an existing granted US Patent to broadenprotection for Nicotine, Vitamins, and Caffeine. The nicotine patentswere a priority for CTT as they offer a smoke-free alternative tosmoking or vaping and would be one of the few oral nicotine productson the market, that dissolve in your mouth in seconds. CTT alsorecently filed two new patents in the US and two in Canada to furtherstrengthen existing patents offering protection for Pharmaceuticals,Cannabinoids, Nicotine, Psychedelics, Caffeine and Vitamins.
Ryan Khouri, CEO of CTT Pharma, stated that we have made a tremendousamount of progress with our patents in a short period of time.Furthermore, these patents give CTT the ability to align with partnersthat have a global reach.
About CTT Pharma
Our patented technology offers protection using many different APIs ondissolvable strips and in other oral deliverables. CTT successfullyreceived Health Canada approval for our dissolvable THC Strips andsold out in weeks with no advertising. CTT’s dissolvable stripsenter the bloodstream once dissolved in the mouth, bypassing the lungsand digestive tract, allowing for better absorption, faster onset, asfast as an injection, and the ability to combine products, such asusing Nicotine and CBD on a dissolvable strip.
CTT will continue to update shareholders as more news becomesavailable .
CTT Pharma – 813-606-0060
Rkhouri@cttpharmaceuticals.com
Copyright (c) 2022 TheNewswire - All rights reserved.